The relevance of APRT deficiency to toxicology lies in its impact on drug metabolism and the potential for nephrotoxicity. Patients with this deficiency may have altered responses to medications that involve purine metabolism, impacting both efficacy and safety. Moreover, the accumulation of DHA itself can be considered a toxic process, causing direct damage to renal tissues.
